BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 15144401)

  • 21. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary.
    Ronnett BM; Shmookler BM; Sugarbaker PH; Kurman RJ
    Anat Pathol; 1997; 2():197-226. PubMed ID: 9575376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors.
    Dewilde K; Moerman P; Leunen K; Amant F; Neven P; Vergote I
    Gynecol Obstet Invest; 2018; 83(1):65-69. PubMed ID: 28689208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification.
    Yemelyanova AV; Vang R; Judson K; Wu LS; Ronnett BM
    Am J Surg Pathol; 2008 Jan; 32(1):128-38. PubMed ID: 18162780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Morphology of borderline mucinous ovarian tumors].
    Karseladze AI
    Arkh Patol; 1989; 51(5):40-6. PubMed ID: 2549923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epithelial ovarian tumors in adolescence: a study of clinical features and treatment].
    Li M; Pan LY; Huang HF; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):598-601. PubMed ID: 15498186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of CA125 immunoreactivity in recurrent or metastatic primary ovarian mucinous neoplasms of the intestinal type.
    Miller K; Millar J; McCluggage WG
    Am J Surg Pathol; 2011 Sep; 35(9):1331-6. PubMed ID: 21836488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Borderline epithelial tumors of the ovary.
    Hart WR
    Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial ovarian tumors of borderline malignancy: long-term follow-up.
    Casey AC; Bell DA; Lage JM; Fuller AF; Nikrui N; Rice LW
    Gynecol Oncol; 1993 Sep; 50(3):316-22. PubMed ID: 8406194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
    Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
    Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mucinous tumors of the ovary. Anatomo-clinical aspects, histological classification, prognostic factors and histogenesis].
    Bouzourene H; Genton CY
    Arch Anat Cytol Pathol; 1997; 45(4):192-8. PubMed ID: 9406476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent intestinal mucinous borderline tumors of the ovary: a report of 5 cases causing problems in diagnosis, including distinction from mucinous carcinoma.
    Irving JA; Clement PB
    Int J Gynecol Pathol; 2014 Mar; 33(2):156-65. PubMed ID: 24487471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of DNA flow cytometry in borderline malignant ovarian tumors.
    Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM
    Cancer; 1996 Aug; 78(4):794-802. PubMed ID: 8756374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucinous tumors of the ovary: interobserver diagnostic variability and utility of sectioning protocols.
    Raab SS; Robinson RA; Jensen CS; Ozkutlu D; O'Reilly PO; Savell VH; Thomas PA
    Arch Pathol Lab Med; 1997 Nov; 121(11):1192-8. PubMed ID: 9372748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
    Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
    Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases.
    Lim-Tan SK; Cajigas HE; Scully RE
    Obstet Gynecol; 1988 Nov; 72(5):775-81. PubMed ID: 3173929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal.
    Prat J
    Adv Anat Pathol; 1999 Sep; 6(5):247-74. PubMed ID: 10472378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases.
    Tabrizi AD; Kalloger SE; Köbel M; Cipollone J; Roskelley CD; Mehl E; Gilks CB
    Int J Gynecol Pathol; 2010 Mar; 29(2):99-107. PubMed ID: 20173494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fertility-sparing surgery for ovarian low malignant potential tumors.
    Rao GG; Skinner EN; Gehrig PA; Duska LR; Miller DS; Schorge JO
    Gynecol Oncol; 2005 Aug; 98(2):263-6. PubMed ID: 15964063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.